Prevention of recurrent hepatitis C after liver transplantation with early interferon and ribavirin treatment.
Department of Surgery, Gastrointestinal Surgery and Liver Transplantation Unit, Pathology Unit, National Cancer Institute, Milan, Italy.
V
V
Mazzaferro
A
A
Tagger
M
M
Schiavo
E
E
Regalia
A
A
Pulvirenti
M L
ML
Ribero
J
J
Coppa
R
R
Romito
L
L
Burgoa
N
N
Zucchini
T
T
Urbanek
F
F
Bonino
D000328:Adult; D000368:Aged; D000998:Antiviral Agents / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006526:Hepatitis C / Q000517:prevention & control*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D016031:Liver Transplantation; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000517:prevention & control* / Q000821:virology; D011994:Recombinant Proteins; D055502:Secondary Prevention
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins